Search results
Weight-loss drugs linked with lower risk of obesity-related cancers
Gulf News· 3 hours agoBlockbuster weight loss and diabetes drugs may lower patients' risk of developing some common types...
What does Labour's win mean for the green transition?
The New Statesman· 5 hours agoThis article was originally published as an edition of the Green Transition, New Statesman...
How Jeremy Hunt survived the breaking of the Blue Wall
The New Statesman· 5 hours ago“This is the Holy Grail,” one Lib Dem told me as we sat waiting for the count in Godalming and Ash....
Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows
Reuters· 5 hours agoPatients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance UK· 6 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
The Conservatives invited this disaster
The New Statesman· 14 hours agoThis is an election result that leaves the Conservative Party fighting for its life. The oldest and most successful political party in the country –...
Bankers Investment Trust: Why TSMC is a safer bet than Nvidia | Trustnet
TrustNet· 1 day agoGlobal stock markets have become obsessed with a narrow group of winners, such as chipmaker Nvidia and obesity drug manufacturers Novo Nordisk and Eli Lilly
What happens if Rishi Sunak loses his seat?
The New Statesman· 1 day agoWhat happens if Rishi Sunak loses his seat of Richmond and Northallerton? A sitting prime minister has never lost their seat in a general election – and...
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Zacks via Yahoo Finance UK· 1 day agoA new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's...
The curse of influencer publishing
The New Statesman· 2 days agoThe slow creep of influencer publishing – the rise of social media stars being handed fat advances and big marketing budgets for memoirs, self-help books...
